Carolyn R Bertozzi's Net Worth

$5.1 Million

Estimate Recalculated Nov 11, 2024 07:36AM EST

Who is Carolyn R Bertozzi

Carolyn R Bertozzi has an estimated net worth of $5.1 Million. This is based on reported shares across multiple companies, which include LILLY ELI & CO, OmniAb, Inc., and ALNYLAM PHARMACEUTICALS, INC..

SEC CIK

Carolyn R Bertozzi's CIK is 0001698766

Past Insider Trading and Trends

2023 was Carolyn R Bertozzi's most active year for acquiring shares with 5 total transactions. Carolyn R Bertozzi's most active month to acquire stocks was the month of May. 2023 was Carolyn R Bertozzi's most active year for disposing of shares, totalling 1 transactions. Carolyn R Bertozzi's most active month to dispose stocks was the month of May. 2020 saw Carolyn R Bertozzi paying a total of $175,034.55 for 1,245 shares, this is the most they've acquired in one year. In 2024 Carolyn R Bertozzi cashed out on 20,000 shares for a total of $0.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

LILLY ELI & CO

Investor
Updated Nov 18, 2020
Form 4
24.91%
1.25K
$140.59
$175.03K
Nov 18, 2020
6.24K
Grant
Nov 16
Form 4
45.51%
1.53K
$114.07
$174.98K
Nov 20, 2019
4.91K
Grant
Nov 18
Form 4
84.13%
1.51K
$115.81
$174.99K
Nov 20, 2018
3.31K
Grant
Nov 19
Form 4
1.76K
$83.18
$146.65K
Nov 22, 2017
1.76K
Grant
Nov 20
Form 3
Feb 23, 2017
Showing 5 results

OmniAb, Inc.

Investor
Updated Nov 01, 2024
Form 4
Nov 01, 2024
93.31K
Options
Nov 01
Form 4
81.85%
60.00K
Jun 21, 2024
133.31K
Options
Jun 18
Form 4
Nov 01, 2023
73.31K
Options
Nov 01
Form 4
112.55%
60.00K
Jun 27, 2023
166.62K
Grant
Jun 23
Form 4/A
200.00K
Jan 05, 2023
200.00K
Grant
Dec 01
Form 4
53.31K
Jan 05, 2023
53.31K
Grant
Jan 03
Form 4
161.85K
Dec 05, 2022
161.85K
Grant
Dec 01
Form 3
Nov 03, 2022
Showing 8 results

ALNYLAM PHARMACEUTICALS, INC.

Investor
Updated May 20, 2024
Form 4
5.23K
May 20, 2024
5.23K
Grant
May 16
Form 4
4.27K
Jan 09, 2023
4.27K
Grant
Jan 05
Form 3
Jan 09, 2023
Showing 3 results